Christine Aylward
InvestorManaging Partner at Magnetic Ventures · Board director at Weave Platform, Inc. · Board director at Amydis, Inc.
United States
Writes $100K – $5M checks · typically $1.5M
Find your path to Christine
529 people in our graph share verified history with Christine — schools, employers, funds. One of them is your warm intro.
About
Christine Aylward is the founder and managing partner of Magnetic Ventures, an early-stage venture capital firm focused on deep tech and life sciences investments. She previously held executive positions at Roche and Sanofi, and has experience building startups.
Contact· self-published, not guessed
Likely email· guessed from name + firm domain, not firm-published
- c•••@magneticvc.comreveal70% confident
Board director at Weave Platform, Inc.
Intro paths
In turn, Christine can intro founders to Weave Platform, Inc.'s investors below.
Weave Platform, Inc.'s investors · 2
Board director at Amydis, Inc.
Intro paths
In turn, Christine can intro founders to Amydis, Inc.'s investors below.
Amydis, Inc.'s investors · 1
Co-founders at Amydis, Inc.

Experience
- Magnetic VenturesFounder & Managing Partnercurrent2018 — presentUnited States
- ProximaBoard Observer & Investorcurrent2026 — present
- Relation TherapeuticsBoard Member & Investorcurrent2021 — presentLondon Area, United Kingdom
- Terrain Biosciences (acquired by Eclipse Bio)Board Member & Investorcurrent2023 — presentBoston, Massachusetts, United States
- Amydis, Inc.Board Member2020 — 2026
- WeaveBoard Member & Investor2024 — 2025
- SameSky Health (acquired by Ground Game Health)Board Member & Investor2020 — 2024
- Foresite Capital ManagementManaging Director2011 — 2017San Francisco, CA
- MakingOfCo-founder & CEO2008 — 2011California, United States
- Genomics, Healthcare Tech, Precision Medicine CompaniesStrategic Advisor2000 — 2009
- Epoch Partners (Acquired by Goldman Sachs)Executive Vice President, Partner, Executive Committee2000 — 2001San Francisco Bay Area
- Salix Pharmaceuticals (Acquired by Valeant Pharmaceuticals)Senior Vice President1998 — 2000Palo Alto, CA
- Sanofi (formerly Rhone-Poulenc Rorer)Advanced Therapeutics and Oncology Division1997 — 1998Collegeville, PA
- Hoffmann-La Roche, Inc.Executive Development Track, Marketing, and Public Policy & Communications1990 — 1997
Skills & more
+10 more
Digital MarketingSocial Media MarketingDigital StrategyBusiness StrategyMarketing StrategyVenture CapitalStrategic PlanningCompetitive AnalysisIntegrated MarketingMergers & AcquisitionsFrom Christine's professional profile.
Deals · 2
Amydis, Inc.Board seat
via Magnetic Ventures · filed Dec 2023 · $6M raise
Weave Platform, Inc.Board seat
via Magnetic Ventures · filed Dec 2023 · $11.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Relation Therapeutics Inc.
Per SEC Form D filings.
Colleagues at Magnetic Ventures
Network8
Investors connected to Christine in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Christine Aylward?
- Christine Aylward is the founder and managing partner of Magnetic Ventures, an early-stage venture capital firm focused on deep tech and life sciences investments. She previously held executive positions at Roche and Sanofi, and has experience building startups.
- Where does Christine Aylward work?
- Christine Aylward is Managing Partner at Magnetic Ventures and Board director at Weave Platform, Inc. and Board director at Amydis, Inc..
- What check size does Christine Aylward write?
- Christine Aylward typically writes checks of $100K – $5M.
- What boards does Christine Aylward sit on?
- Christine Aylward holds tracked board seats at Amydis, Inc., Relation Therapeutics Inc., Weave Platform, Inc..
- Where did Christine Aylward go to school?
- Christine Aylward studied at Rowan University (Bachelor of Arts - BA).
Same school
Also attended Rowan University14
+ 8 more
Shared employers
Also worked at Proxima3
Also worked at Foresite Capital Management37
+ 31 more
Also worked at Epoch Partners (Acquired by Goldman Sachs)2,000
+ 1,994 more
Also worked at Sanofi (formerly Rhone-Poulenc Rorer)175
+ 169 more
)











)
)
)
























